CoChat

Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis

Open access
Hasler, William L., Wilson, Laura A., Nguyen, Linda A., Snape, William J., Abell, Thomas L., Koch, Kenneth L., McCallum, Richard W., Pasricha, Pankaj J., Sarosiek, Irene, Farrugia, Gianrico, Grover, Madhusudan, Lee, Linda A., Miriel, Laura, Tonascia, James, Hamilton, Frank A., Parkman, Henry P., Pasricha, Pankaj Jay, Clarke, John, Kim, Yale, Nguyen, Linda, Ullah, Nighat, Snape, William, DeVole, Nata, Greene, Mary, Lee, Candice, Ponsetto, Courtney, Shetler, Katerina, Parkman, Henry P., Kantor, Steven, Lytes, Vanessa, Palit, Amiya, Simmons, Kellie, McCallum, Richard W., Hejazi, Reza, Roeser, Kathy, Sarosiek, Irene, Vasquez, Denise, Vega, Natalia, Abell, Thomas, Beatty, Karen, Hatter, Lisa, Howard, Ronna, Nowotny, Lindsay, Tang, Shou, Amin, Om S., Henry, Olivia, Kedar, Archana, McNair, Valerie, Pruett, Susanne, Smith, Margaret, Spree, Danielle, Hasler, William, Castle, Michelle, Coleski, Radoslav, Wootten, Sophanara, Koch, Kenneth, Baxter, Lynn, Brown, Anya, Culler, Samantha, Hooker, Judy, Stuart, Paula, Farrugia, Gianrico, Grover, Madhusudan, Bernard, Cheryl, Calles-Escandon, Jorge, Serrano, Jose, Hamilton, Frank, James, Steven, Torrance, Rebecca, Van Raaphorst, Rebekah, Tonascia, James, Belt, Patricia, Hallinan, Erin Corless, Colvin, Ryan, Donithan, Michele, Green, Mika, Isaacson, Milana, Kim, Wana, Lee, Linda, May, Patrick, Miriel, Laura, Sternberg, Alice, Van Natta, Mark, Vaughn, Ivana, Wilson, Laura, Yates, Katherine · 2019 · Clinical Gastroenterology and Hepatology
Cited by 84

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND & AIMS: Many patients with gastroparesis are prescribed opioids for pain control, but indications for opioid prescriptions and the relationship of opioid use to gastroparesis manifestations are undefined. We characterized associations of use of potent vs weaker opioids and presentations of diabetic and idiopathic gastroparesis. METHODS: We collected data on symptoms, gastric emptying, quality of life, and health care resource use from 583 patients with gastroparesis (>10% 4-h scintigraphic retention) from the National Institute of Diabetes and Digestive and Kidney Diseases Gastroparesis Consortium, from January 2007 through November 2016. Patients completed medical questionnaires that included questions about opioid use. The opioid(s) were categorized for potency relative to oral morphine. Symptom severities were quantified by Patient Assessment of Upper Gastrointestinal Disorders Symptoms questionnaires. Subgroup analyses compared patients on potent vs weaker opioids and opioid effects in diabetic vs idiopathic etiologies. RESULTS: Forty-one percent of patients were taking opioids; 82% of these took potent agents (morphine, hydrocodone, oxycodone, methadone, hydromorphone, buprenorphine, or fentanyl). Abdominal pain was the reason for prescription for 61% of patients taking opioids. Mean scores for gastroparesis, nausea/vomiting, bloating/distention, abdominal pain, and constipation scores were higher in opioid users (P ≤ .05). Opioid use was associated with greater levels of gastric retention, worse quality of life, increased hospitalization, and increased use of antiemetic and pain modulator medications compared with nonusers (P ≤ .03). Use of potent opioids was associated with worse gastroparesis, nausea/vomiting, upper abdominal pain, and quality-of-life scores, and more hospitalizations compared with weaker opioids (tapentadol, tramadol, codeine, or propoxyphene) (P ≤ .05). Opioid use was associated with larger increases in gastric retention in patients with idiopathic vs diabetic gastroparesis (P = .008). CONCLUSIONS: Opioid use is prevalent among patients with diabetic or idiopathic gastroparesis, and is associated with worse symptoms, delays in gastric emptying, and lower quality of life, as well as greater use of resources. Potent opioids are associated with larger effects than weaker agents. These findings form a basis for studies to characterize adverse outcomes of opioid use in patients with gastroparesis and to help identify those who might benefit from interventions to prevent opioid overuse.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2018.10.013

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 84

Metadata

Authors
Hasler, W. L., Wilson, L. A., Nguyen, L. A., Snape, W. J., Abell, T. L., Koch, K. L., McCallum, R. W., Pasricha, P. J., Sarosiek, I., Farrugia, G., Grover, M., Lee, L. A., Miriel, L., Tonascia, J., Hamilton, F. A., Parkman, H. P., Pasricha, P. J., Clarke, J., Kim, Y., Nguyen, L., Ullah, N., Snape, W., DeVole, N., Greene, M., Lee, C., Ponsetto, C., Shetler, K., Parkman, H. P., Kantor, S., Lytes, V., Palit, A., Simmons, K., McCallum, R. W., Hejazi, R., Roeser, K., Sarosiek, I., Vasquez, D., Vega, N., Abell, T., Beatty, K., Hatter, L., Howard, R., Nowotny, L., Tang, S., Amin, O. S., Henry, O., Kedar, A., McNair, V., Pruett, S., Smith, M., Spree, D., Hasler, W., Castle, M., Coleski, R., Wootten, S., Koch, K., Baxter, L., Brown, A., Culler, S., Hooker, J., Stuart, P., Farrugia, G., Grover, M., Bernard, C., Calles-Escandon, J., Serrano, J., Hamilton, F., James, S., Torrance, R., Van Raaphorst, R., Tonascia, J., Belt, P., Hallinan, E. C., Colvin, R., Donithan, M., Green, M., Isaacson, M., Kim, W., Lee, L., May, P., Miriel, L., Sternberg, A., Van Natta, M., Vaughn, I., Wilson, L., & Yates, K.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2019-06
Volume
17
Issue
7
Pages
1285-1294.e1
ISSN
1542-3565 (ISSN-L)
OpenAlex
W2897597485
Cited by
84
References
4
FWCI
6.87
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis. https://app.cochat.ai/papers/10.1016/j.cgh.2018.10.013
The paper
Hasler, W. L., Wilson, L. A., Nguyen, L. A., Snape, W. J., Abell, T. L., Koch, K. L., McCallum, R. W., Pasricha, P. J., Sarosiek, I., Farrugia, G., Grover, M., Lee, L. A., Miriel, L., Tonascia, J., Hamilton, F. A., Parkman, H. P., Pasricha, P. J., Clarke, J., Kim, Y., . . . Yates, K. (2019). Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2018.10.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.